Mackenzie Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
+66,152
| New | +$1.18M | ﹤0.01% | 973 |
|
|
2025
Q1 | – | Sell |
-6,820
| Closed | -$203K | – | 1752 |
|
|
2024
Q4 | $203K | Buy |
+6,820
| New | +$203K | ﹤0.01% | 1562 |
|
|
2022
Q1 | – | Sell |
-12,078
| Closed | -$907K | – | 1476 |
|
|
2021
Q4 | $907K | Buy |
12,078
+4,620
| +62% | +$347K | ﹤0.01% | 921 |
|
|
2021
Q3 | $866K | Buy |
7,458
+3,282
| +79% | +$381K | ﹤0.01% | 927 |
|
|
2021
Q2 | $926K | Buy |
+4,176
| New | +$926K | ﹤0.01% | 886 |
|
|
2018
Q2 | – | Sell |
-23,600
| Closed | -$514K | – | 1042 |
|
|
2018
Q1 | $514K | Buy |
+23,600
| New | +$514K | ﹤0.01% | 728 |
|